Table 2 Admission characteristics, hemostasis disorders during VA-ECMO and patient outcomes according to brain damage or not
From: Proceedings of Réanimation 2017, the French Intensive Care Society International Congress
Characteristic | No brain damage | Patients with brain damage | |
|---|---|---|---|
(n = 800) | Ischemic stroke (n = 47) | Cerebral bleeding (n = 25) | |
Age (years) | 50 ± 15 | 50 ± 16 | 48 ± 18 |
Male sex [n (%)] | 568 (71) | 32 (68) | 12 (48) |
SAPS II | 72 [54–85] | 70 [61–86] | 74 [57–90] |
SOFA score | 5 [3–14] | 5 [3–8] | 3 [3–7] |
Biologic values (J1 ECMO) | |||
Lactates (mmol/L) | 6 [2.7–11.1] | 5 [2.9–10.1] | 4 [4.0–10.0] |
PT (%) | 45 [30–62] | 54 [34–65.8] | 47 [27.5–54] |
ACT | 1.6 [1.2–2.3] | 1.4 [1.1–1.8] | 1.8 [1.4–3] |
Fibrinogen (g/L) | 3.0 [2.0–5.0] | 3.0 [2.4–5.0] | 4.0 [1.7–4.0] |
Platelets (×109/L) | 155 [96–215] | 163 [100–246] | 86 [56.5–164] |
Type of ECMO | |||
Peripheral | 698 (87) | 35 (74) | 20 (80) |
Switch to central ECMO | 38 (5) | 2 (4) | 4 (16) |
Central | 107 (13) | 12 (26) | 5 (25) |
Intra-aortic balloon pump | 265 (33) | 16 (34) | 5 (25) |